Juno grows series A

Cancer immunotherapy play Juno Therapeutics Inc. (Seattle, Wash.) said it expanded its series A and has now raised more than $145 million in the round. Last month, the company debuted and said it raised $120 million in the A round. New investors Bezos Expeditions and Venrock participated in the expansion. Venrock's Anthony Evnin will join Juno's board. ...